Turan İlker, Dedeli Özden, Bor Serhat, İlter Tankut
Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey.
Turk J Gastroenterol. 2014 Dec;25(6):650-6. doi: 10.5152/tjg.2014.6990.
BACKGROUND/AIMS: Although probiotics have been extensively studied in irritable bowel syndrome, data on the impact of probiotics on chronic constipation are scarce. We aimed to evaluate the effects of kefir, which is a probiotic fermented milk product, on the symptoms, colonic transit, and bowel satisfaction scores of patients with chronic constipation.
Twenty consecutive patients with functional constipation according to the Rome II criteria were divided into two groups based on their colon transit studies: 1. The normal transit (NT) group (n=10); and 2. The slow transit (ST) group (n=10). After a baseline period, 500 mL/day of a probiotic kefir beverage was administered to all patients for 4 weeks. Defecation parameters (stool frequency, stool consistency, degree of straining, laxative consumption) were recorded in diaries daily by the patients. Bowel satisfaction scores were assessed using a visual analog scale. The colon transit study was repeated in the ST group at the end of the study.
At the end of the study, the patients showed an increased stool frequency (p<0.001), improved stool consistency (p=0.014), and decreased laxative consumption (p=0.031). The degree of straining during evacuation showed a tendency to improve after kefir administration; however, this was not statistically significant (p=0.18). A repeat transit study showed an acceleration of colonic transit in the ST group (p=0.013). Bowel satisfaction scores also improved (p<0.001).
This pilot study shows that kefir has positive effects on the symptoms of constipation. Our results also suggest that kefir improves bowel satisfaction scores and accelerates colonic transit. Controlled trials are warranted to confirm these findings.
背景/目的:尽管益生菌在肠易激综合征中已得到广泛研究,但关于益生菌对慢性便秘影响的数据却很少。我们旨在评估开菲尔(一种益生菌发酵奶制品)对慢性便秘患者的症状、结肠传输及肠道满意度评分的影响。
根据罗马II标准,连续纳入20例功能性便秘患者,根据结肠传输研究将其分为两组:1. 正常传输(NT)组(n = 10);2. 慢传输(ST)组(n = 10)。在基线期后,所有患者每天饮用500 mL益生菌开菲尔饮料,持续4周。患者每天通过日记记录排便参数(大便频率、大便性状、用力程度、泻药使用情况)。使用视觉模拟量表评估肠道满意度评分。研究结束时,对ST组重复进行结肠传输研究。
研究结束时,患者大便频率增加(p < 0.001),大便性状改善(p = 0.014),泻药使用量减少(p = 0.031)。服用开菲尔后,排便时的用力程度有改善趋势;然而,差异无统计学意义(p = 0.18)。重复的传输研究显示ST组结肠传输加快(p = 0.013)。肠道满意度评分也有所改善(p < 0.001)。
这项初步研究表明,开菲尔对便秘症状有积极影响。我们的结果还表明,开菲尔可提高肠道满意度评分并加速结肠传输。需要进行对照试验来证实这些发现。